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An important consideration in bringing a new molecule through development is speed to clinic. Increased 
utilization of high throughput tools, process platforms, and in silico modelling can allow for screening of more 
conditions in a shorter period of time, enabling either a faster development time or increased optimization 
capability.  
 
Here we discuss the application of a basic metabolic flux analysis model to better understand and manipulate 
mammalian cell culture performance. With this tool, we aim to improve hypothesis-generation and design 
experiments more rationally. Studies were performed across multiple CHO cell lines producing various 
recombinant enzyme products in both 10L benchtop bioreactors and an AMBR15 small-scale system. Based on 
predictions from the metabolic flux analysis model, certain amino acids were supplemented in the media to 
modulate growth rate, titer, and metabolic byproducts. Effects on these parameters were then assessed and 
compared across process scales and cell lines. 
 
This case study demonstrates the utility of high throughput process development tools in conjunction with 
metabolic modelling for better understanding of existing processes and cell lines. This method of screening 
provides the comprehensive data sets that are necessary to elucidate effects of amino acid supplementation on 
mammalian cell culture performance. Additionally, application of in silico modelling techniques such as this may 
lead to fewer required experiments, shortening development timelines.  
